BENJAMIN NISSLEY: Open Payments
NPI 1023565132 · ARRINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 17 payments from 10 companies in 2025. Trend: 2023 $216 · 2024 $404 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| PFIZER INC. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: VRAYLAR, Kerendia, CAPLYTA, AIRSUPRA, NURTEC ODT, PURIFIED CORTROPHIN GEL, GARDASIL 9, Dexcom G6 Transmitter.
Industry payments across VA — which companies pay providers there.
